175 related articles for article (PubMed ID: 9865506)
1. Effect of tachykinin receptor antagonists in experimental neuropathic pain.
Coudoré-Civiale MA; Courteix C; Eschalier A; Fialip J
Eur J Pharmacol; 1998 Nov; 361(2-3):175-84. PubMed ID: 9865506
[TBL] [Abstract][Full Text] [Related]
2. Effects of tachykinin receptor antagonists on the rat jejunal distension pain response.
McLean PG; Garcia-Villar R; Fioramonti J; Buéno L
Eur J Pharmacol; 1998 Mar; 345(3):247-52. PubMed ID: 9592022
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an involvement of tachykinins in allodynia in streptozocin-induced diabetic rats.
Coudoré-Civiale M; Courteix C; Boucher M; Fialip J; Eschalier A
Eur J Pharmacol; 2000 Jul; 401(1):47-53. PubMed ID: 10915836
[TBL] [Abstract][Full Text] [Related]
4. NK2 receptors mediate tachykinin-induced contractions of rat uterus during the oestrous cycle.
Moodley N; Lau WA; Pennefather JN; Story ME; Fisher L
Eur J Pharmacol; 1999 Jul; 376(1-2):53-60. PubMed ID: 10440089
[TBL] [Abstract][Full Text] [Related]
5. Involvement of spinal tachykinin NK1 and NK2 receptors in detrusor hyperreflexia during chemical cystitis in anaesthetized rats.
Lecci A; Giuliani S; Santicioli P; Maggi CA
Eur J Pharmacol; 1994 Jul; 259(2):129-35. PubMed ID: 7957606
[TBL] [Abstract][Full Text] [Related]
6. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
Yashpal K; Hui-Chan CW; Henry JL
Eur J Pharmacol; 1996 Jul; 308(1):41-8. PubMed ID: 8836630
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of non-peptidic tachykinin receptor antagonists on Ca2+ channels.
Lombet A; Spedding M
Eur J Pharmacol; 1994 Mar; 267(1):113-5. PubMed ID: 8206125
[TBL] [Abstract][Full Text] [Related]
8. Functional characterisation of tachykinin receptors mediating ion transport in porcine jejunum.
Thorbøll JE; Bindslev N; Hansen MB; Schmidt P; Skadhauge E
Eur J Pharmacol; 1998 Oct; 359(2-3):271-9. PubMed ID: 9832399
[TBL] [Abstract][Full Text] [Related]
9. Role of tachykinin NK1, NK2 and NK3 receptors in the modulation of visceral hypersensitivity in the rat.
Gaudreau GA; Plourde V
Neurosci Lett; 2003 Nov; 351(2):59-62. PubMed ID: 14583381
[TBL] [Abstract][Full Text] [Related]
10. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
11. The potency of the novel tachykinin receptor antagonist CGP49823 at rat and gerbil motoneurones in vitro.
Pozza MF; Olpe HR; Ofner S; Schoeffel C; Evans RH
Eur J Pharmacol; 1998 Jan; 342(2-3):203-8. PubMed ID: 9548386
[TBL] [Abstract][Full Text] [Related]
12. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Deschamps K; Couture R
Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat.
Dableh LJ; Yashpal K; Rochford J; Henry JL
Eur J Pharmacol; 2005 Jan; 507(1-3):99-105. PubMed ID: 15659299
[TBL] [Abstract][Full Text] [Related]
14. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical and pharmacological study of tachykinins in the rat and guinea-pig prostate glands.
Buljubasich S; Lau WA; Pennefather JN; Ventura S
Eur J Pharmacol; 1999 Sep; 380(2-3):137-44. PubMed ID: 10513573
[TBL] [Abstract][Full Text] [Related]
17. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
18. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
[TBL] [Abstract][Full Text] [Related]
20. Activity of SR 142801 at peripheral tachykinin receptors.
Patacchini R; Barthò L; Holzer P; Maggi CA
Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
